Soluble Epoxide Hydrolase Inhibitors and their Potential for Treatment of Multiple Pathologic Conditions
Keywords: AR9281; BOEHRINGER INGELHEIM; BTP2; EPHX2; Epoxyeicosanoids; HAMMOCK LABORATORY PHARMACOPHORE MODEL; HOFFMAN LA ROCHE; MCAO (Middle Cerebral; MERCK; Multiple Pathologic Conditions; TAISHO; adamantane piperidinyl ureas; alcohol; alkyl spacers; am-ide; ameliorate; benzoheterocycle; carbamate; cytosol; eicosanoids; endothelial-derived hyperpolarizing factor; epoxyeicosatrienoic acid; farnesyl; geranyl-geranyl; homodimeric bifunctional enzyme; ketone; linoleic acid; piperidinyl ureas; pyrophosphates; sEH; secondary pharmacophore; soluble epoxide hydrolase; transient ischemic attack (TIA); vicinal diols
Document Type: Research Article
Publication date: 2011-02-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.